Home Healthcare Pharmaceuticals Anti-obesity Drugs Market

Anti-obesity Drugs Market Size, Share & Trends Analysis Report By Drug Class (GLP-1 Receptor Agonists, Dual GIP/GLP-1 Agonists, Triple or Multi-Receptor Agonists, Centrally Acting Sympathomimetics, Peripherally Acting Lipase Inhibitors), By Type (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, E-commerce) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 28, 2026 | Author: Dhanashri B | Format: | Report Code: SR7876DR | Pages: 210
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Anti-obesity Drugs Market Size Analysis
    1. Introduction
    2. Anti-obesity Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. GLP-1 Receptor Agonists
      2. Dual GIP/GLP-1 Agonists
      3. Triple or Multi-Receptor Agonists
      4. Centrally Acting Sympathomimetics
      5. Peripherally Acting Lipase Inhibitors
    3. Anti-obesity Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription Drugs
      2. OTC Drugs
    4. Anti-obesity Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. E-commerce
  7. North America Anti-obesity Drugs Market Size Analysis
    1. Introduction
    2. Anti-obesity Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. GLP-1 Receptor Agonists
      2. Dual GIP/GLP-1 Agonists
      3. Triple or Multi-Receptor Agonists
      4. Centrally Acting Sympathomimetics
      5. Peripherally Acting Lipase Inhibitors
    3. Anti-obesity Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription Drugs
      2. OTC Drugs
    4. Anti-obesity Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. E-commerce
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
  8. Europe Anti-obesity Drugs Market Size Analysis
    1. Introduction
    2. Anti-obesity Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. GLP-1 Receptor Agonists
      2. Dual GIP/GLP-1 Agonists
      3. Triple or Multi-Receptor Agonists
      4. Centrally Acting Sympathomimetics
      5. Peripherally Acting Lipase Inhibitors
    3. Anti-obesity Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription Drugs
      2. OTC Drugs
    4. Anti-obesity Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. E-commerce
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
  9. APAC Anti-obesity Drugs Market Size Analysis
    1. Introduction
    2. Anti-obesity Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. GLP-1 Receptor Agonists
      2. Dual GIP/GLP-1 Agonists
      3. Triple or Multi-Receptor Agonists
      4. Centrally Acting Sympathomimetics
      5. Peripherally Acting Lipase Inhibitors
    3. Anti-obesity Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription Drugs
      2. OTC Drugs
    4. Anti-obesity Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. E-commerce
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
  10. Middle East and Africa Anti-obesity Drugs Market Size Analysis
    1. Introduction
    2. Anti-obesity Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. GLP-1 Receptor Agonists
      2. Dual GIP/GLP-1 Agonists
      3. Triple or Multi-Receptor Agonists
      4. Centrally Acting Sympathomimetics
      5. Peripherally Acting Lipase Inhibitors
    3. Anti-obesity Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription Drugs
      2. OTC Drugs
    4. Anti-obesity Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. E-commerce
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
  11. LATAM Anti-obesity Drugs Market Size Analysis
    1. Introduction
    2. Anti-obesity Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. GLP-1 Receptor Agonists
      2. Dual GIP/GLP-1 Agonists
      3. Triple or Multi-Receptor Agonists
      4. Centrally Acting Sympathomimetics
      5. Peripherally Acting Lipase Inhibitors
    3. Anti-obesity Drugs Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription Drugs
      2. OTC Drugs
    4. Anti-obesity Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. E-commerce
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. GLP-1 Receptor Agonists
        2. Dual GIP/GLP-1 Agonists
        3. Triple or Multi-Receptor Agonists
        4. Centrally Acting Sympathomimetics
        5. Peripherally Acting Lipase Inhibitors
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Drugs
        2. OTC Drugs
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. E-commerce
  12. Competitive Landscape
    1. Anti-obesity Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Novo Nordisk (Denmark)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Lilly (US)
    3. Pfizer Inc. (US)
    4. Amgen Inc. (US)
    5. Hoffmann-La Roche Ltd. (Switzerland)
    6. AstraZeneca (UK)
    7. Merck & Co., Inc. (US)
    8. Sanofi (France)
    9. Boehringer Ingelheim (Germany)
    10. Structure Therapeutics (US)
    11. Viking Therapeutics (US)
    12. Regeneron Pharmaceuticals (US)
    13. Altimmune (US)
    14. Metsera (US)
    15. Zealand Pharma (Denmark)
    16. Hanmi Pharmaceutical (South Korea)
    17. Innovent Biologics (China)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.